Track the マニー株式会社 share price and the full insider trade history of the company, a publicly traded company based in Japan. Shares are listed on JP JP, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, マニー株式会社 has published 9 insider filings. Market capitalisation: €148.9bn. The latest transaction was disclosed on 3 August 2026 (Holding update). Among the most active insiders: Mitsubishi UFJ Financial Group Inc.. All data is accessible without an account.
Analysts rate マニー株式会社 Buy (bullish), based on 7 analysts. Average price target: JP¥1,889.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
9 of 9 declarations
マニー株式会社 is a company in the health and pharmaceutical sector, listed on the XTKS market. It specializes in the development and distribution of pharmaceutical products.